PharmatecaPharmatecaФарматека2073-40342414-9128Bionika Media280316ArticlesСтатьиResearch ArticleGOLOVNAYa BOL' I PSIKhIChESKIE RASSTROYSTVA: VZGLYaD NEVROLOGA I PSIKhIATRAГОЛОВНАЯ БОЛЬ И ПСИХИЧЕСКИЕ РАССТРОЙСТВА: ВЗГЛЯД НЕВРОЛОГА И ПСИХИАТРАAzimovaYu. EАзимоваЮ. Э

к.м.н, врач-невролог; н.с. отдела неврологии и клинической нейрофизиологии

azimova.j@mail.ruMagomedovaA. NМагомедоваА. НУниверситетская клиника головной боли, МоскваГБОУ ВПО «Первый МГМУ им. И.М. Сеченова» Минздрава России, МоскваУниверситетская клиника головной боли, Москва20112013203sNO3s (2013)№3s (2013)394425022023Copyright ©; 2013, Bionika MediaCopyright ©; 2013, ООО «Бионика Медиа»2013Bionika MediaООО «Бионика Медиа»https://journals.eco-vector.com/2073-4034/article/view/280316

Emotional and affective disorders and some forms of headache have a close relationship. The significance of anxiety and depressive disorders is so great that in the International Classification of Headache Disorders III (2013), the section «Headache associated with mental disorders» has been greatly expanded. This enables making better diagnosis and extends approaches to drug therapy in patients with severe and resistant to treatment forms of headache.

Эмоционально-аффективные расстройства и многие формы головной боли имеют тесную взаимосвязь. Значимость тревожнодепрессивных расстройств столь велика, что в Международной классификации головных болей III (2013) раздел «Головная боль, связанная с психическими нарушениями» был значительно расширен. Это дает возможность лучшей диагностики и позволяет расширить подходы к фармакотерапии пациентов с тяжелыми и труднокурабельными формами головной боли.

migrainedisordersrebound headachechronic headacheanxietydepressionantidepressantsescitalopramмигреньрасстройстваабузусная головная больхроническая головная больтревогадепрессияантидепрессантыэсциталопрамAlamy S, Zhang W, Varia I, et al. Escitalopram in specific phobia: results of a placebo-controlled pilot trial. J Psychopharmacol 2008; 22:157-61.Azimova Y, Sergeev A, Skorobogatykh K. BDNF gene polymorphysm RS2049046 in episodic and chronic migraine. J Headache and Pain 2013;(Suppl. 1):16.Breslau N, Davis G. Migraine, physical health and psychiatric disorder: a prospective epidemiologic study in young adults. J Psychiatr Res 1993;2:211-21.Breslau N, Davis GC, Schultz LR. Migraine and major depression: a longitudinal study. Headache 1994;34:387-93.Corbelli I, Caproni S, Eusebi P, et al. Drug-dependence behaviour and outcome of med-ication-overuse headache after treatment. J Headache Pain 2012;13:653-60.Cupini LM, De Murtas M, Costa C, et al. Obsessive-compulsive disorder and migraine with medication-overuse headache. Headache 2009;49:1005-13.Grazzi L, Chiapparini L, Ferraro S, et al. Chronic migraine with medication overuse pre-post withdrawal of symptomatic medication: clinical results and FMRI correlations. Headache 2010;50:998-1004.Hamelsky SW, Lipton RB. Psychiatric comorbidity of migraine. Headache 2006;46(9):1327-33.Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 33;629-808.Lanska JR, Lanska DJ. Alice in Wonderland Syndrome: somesthetic vs visual perceptual disturbance. Neurology 2013;26:1262-64.Merikangas KR. Psychopathology and headache syndromes in the community. Headache 1994;34:S17-S26.Merikangas KR, Angst J, Isler H. Migraine and psychopathology. Results of the Zurich cohort study of young adults. Arch Gen Psychiatry 1990;47:849-53.Moja PL, Cusi C, Sterzi RR, et al. Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches. Cochrane Database Syst Rev 2005;20(3).Giannini G, Zanigni S, Grimaldi D, et al. Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study. J Headache and Pain 2013;14:49.Radat F, Milowska D, Valade D. Headaches secondary to psychiatric disorders (HSPD): a retrospective study of 87 patients. Headache 2011;51;789-95.Radat F, Swendsen J. Psychiatric comorbidity in migraine: a review. Cephalalgia 2005;25(3):165-78.Radat F, Chanraud S, Di Scala G, et al. Psychological and neuropsychological correlates of dependence-related behaviour in medication overuse headaches: a one year follow-up study. J Headache Pain 2013;14:59.Rome HP Jr, Rome JD. Limbically augmented pain syndrome (LAPS): kindling, corticolimbic sensitization, and the convergence of affective and sensory symptoms in chronic pain disorders. Pain Med 2000;1(1):7-23.Schur EA, Noonan C, Buchwald D, et al. A twin study of depression and migraine: evidence for a shared genetic vulnerability. Headache 2009;49:1493-502.Stein DJ, Andersen EW, Tonnoir B, Fineberg N. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study. Curr Med Res Opin 2007;23:701-11.Tarlaci S. Escitalopram and venlafaxine for the prophylaxis of migraine headache without mood disorders. Clin Neuropharmacol 2009; 32:254-58.Waldie KE, Poulton R. Physical and psychological correlates of primary headache in young adulthood: a 26 year longitudinal study. J Neurol Neurosurg Psychiatry 2002;72(1): 86-92.Wolff HG. Personality features and reactions of subjects with migraine. Arch Neurol Psychiatry 1937;37:895.